Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 108
Selected: 0
NCT IDTitle
NCT02438631Placental Passage and Disposition of Drugs: A Physiology-based Approach
NCT00959894Evaluating Once Daily Etravirine in Treatment-Naive Adults With HIV Infection
NCT03404635Monotherapy Anticoagulation To Expedite Home Treatment of Venous Thromboembolism
NCT01837862A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas
NCT04240210Integrase Regimen Switch to Symtuza to Increase Tolerability/Adherence (SYMita)
NCT02951052Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine From Current Antiretroviral Regimen in Virologically Suppressed HIV-1-infected Adults
NCT00578240Molecular Studies and Clinical Correlations in Human Prostatic Disease
NCT00855413HIV Viremia and Persistence in Acutely HIV-Infected Patients Treated With Darunavir/Ritonavir and Etravirine
NCT06232551Alerting Providers at Patient Hospital Discharge to Consider Prescribing Rivaroxaban to Reduce Venous Thromboembolism
NCT03823924Changes in Body Composition Under Ustekinumab in PsA
NCT03093272A Study of Docetaxel + ARN-509 in Castration-Resistant Prostate Cancer
NCT00002132Randomized, Controlled, Double-Blind Study of Itraconazole Oral Solution Versus Fluconazole Tablets for the Treatment of Esophageal Candidiasis.
NCT00214552Evaluate the Effects on Asthma Control of Rabeprazole Given Twice Daily in Subjects With Asthma.
NCT03397186Immune Changes Following Trabectedin in Patients With Metastatic or Unresectable Sarcoma
NCT01848028PsoBest - The German Psoriasis Registry
NCT03696160The Late Presenter Treatment Optimisation Study
NCT07110844Teclistamab-Daratumumab in AL Amyloidosis
NCT05117931A Study of Amivantamab in People With Esophagogastric Cancer
NCT02955810Cyclophosphamide-Bortezomib-Dexamethasone (CyBorD) With Daratumumab (DARA)
NCT00006371A Phase II Trial of Early Medical Adrenalectomy for "D0.5" Prostate Cancer
NCT04089345Stelara fOr ChRonic AntibioTic rEfractory pouchitiS
NCT04162366A Research Study to Show Aprocitentan is Efficacious and Safe to Treat Patients With Uncontrolled Blood Pressure and Chronic Kidney Disease.
NCT02622581Clinical Research Platform Into Molecular Testing, Treatment and Outcome of (Non-)Small Cell Lung Carcinoma Patients
NCT02987829Phase 1/2A Study of TRC253, an Androgen Receptor Antagonist, in Metastatic Castration-resistant Prostate Cancer Patients
NCT01241760VX-950-C211 - A Dosing Regimen Study (Twice Daily Versus Every 8 Hours) of Telaprevir in Treatment-naïve Participants With Genotype 1 Chronic Hepatitis C Virus Infection
NCT02745054Safety of Oral Anticoagulants Registry
NCT03283917Daratumumab, Ixazomib, and Dexamethasone in AL Amyloidosis
NCT00000975A Study of Itraconazole in the Treatment and Prevention of Histoplasmosis, a Fungal Infection, in Patients With AIDS
NCT05971602Efficacy and Safety Evaluation of Two to Four Months of Treatment With the Combination Regimens of DBOS and PBOS in Adults With Pulmonary Tuberculosis
NCT05896748Study to Assess the Effects of Cabotegravir (CAB) and Rilpivirine (RPV) Long-Acting (LA) Injections Following Sub-cutaneous (SC) Administration Compared With Intramuscular (IM) Administration in Adult Participants Living With Human Immunodeficiency Virus (HIV-1) Infection in the FLAIR Study
NCT02867020Study of Abiraterone Acetate Plus ADT Versus APALUTAMIDE Versus Abiraterone and APALUTAMIDE in Patients With Advanced Prostate Cancer With Non-castrate Testosterone Levels
NCT05109559Ad26.COV2.S as a Heterologous Booster in Adults After Single- or Two-Dose of Inactivated COVID-19 Vaccine
NCT06083922A Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS)
NCT03522259Rivaroxaban as Thrombosis Prophylaxis in Bariatric Surgery
NCT03556332A Study of Carfilzomib, Lenalidomide, Dexamethasone and Daratumumab for Patients With Relapsed/Refractory Myeloma With Salvage Autologous Hematopoietic Cell Transplantation
NCT02838693Assessing Progression to Type-2 Diabetes (APT-2D): A Prospective Cohort Study Expanded From BRITE-SPOT (Bio-bank and Registry for StratIfication and Targeted intErventions in the Spectrum Of Type 2 Diabetes)
NCT03541174A Research Study to Show the Effect of Aprocitentan in the Treatment of Difficult to Control (Resistant) High Blood Pressure (Hypertension) and Find Out More About Its Safety
NCT05285137Study of CD388 Intramuscular or Subcutaneous Administration in Healthy Subjects
NCT03655223Early Check: Expanded Screening in Newborns
NCT03450057Efficacy of Daratumumab in Patients With Relapsed/Refractory Myeloma With Renal Impairment
NCT00177164Risperdal Consta for Bipolar Disorder
NCT04394936An Explorative Psoriasis Biomarker Study
NCT01641367A5288/MULTI-OCTAVE: Management Using Latest Technologies to Optimize Combination Therapy After Viral Failure
NCT03939182Abexinostat and Ibrutinib in Diffuse Large B-cell Lymphoma and Mantle Cell Lymphoma
NCT03236428Phase II Study of the CD38 Antibody Daratumumab in Patients With High-Risk MGUS and Low-Risk Smoldering Multiple Myeloma
NCT03503344Apalutamide With or Without Stereotactic Body Radiation in Treating Castration-Resistant Prostate Cancer
NCT03586570A Study to Evaluate How Aprocitentan is Safe and How it is Absorbed and Broken Down in the Body of Japanese and Caucasian Subjects
NCT04399551A Study Evaluating Implementation Strategies for Cabotegravir (CAB)+ Rilpivirine (RPV) Long-acting (LA) Injectables for Human Immunodeficiency Virus (HIV)-1 Treatment in European Countries
NCT04371380Pharmacokinetic Study of Cabotegravir and Rilpivirine Long-acting Intramuscular Injections in Healthy Adult Participants
NCT06066346A Study of Talquetamab for People With Multiple Myeloma Who Have Received BCMA CAR T-Cell Therapy